Adora Ndu

Insider Reports History

Location
Montrouge, France
Signature
/s/ Jennifer J. Rhodes, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Adora Ndu:

Company Role Class Num Shares Value Price $ Report Date Ownership
ACADIA PHARMACEUTICALS INC Director Common Stock 24,801 $432,529 $17.44 29 May 2025 Direct
DBV Technologies S.A. Director Ordinary Shares 1,825 $1,624 $0.8900 06 Feb 2024 Direct
ACADIA PHARMACEUTICALS INC Director Restricted Stock Units 8,107 $0 $15.28 29 May 2025 Direct
ACADIA PHARMACEUTICALS INC Director Director Stock Options (Right to Buy) 13,793 29 May 2025 Direct

Insider Reports Filed by Adora Ndu

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ACAD ACADIA PHARMACEUTICALS INC 29 May 2025 4 $0 4 Director 02 Jun 2025, 18:05
ACAD ACADIA PHARMACEUTICALS INC 12 Oct 2024 2 $0 4 Director 15 Oct 2024, 18:05
ACAD ACADIA PHARMACEUTICALS INC 29 May 2024 4 $0 4 Director 31 May 2024, 18:00
DBVT DBV Technologies S.A. 06 Feb 2024 1 +$1,624 4 Director 08 Feb 2024, 17:02
ACAD ACADIA PHARMACEUTICALS INC 12 Oct 2023 2 $0 4 Director 16 Oct 2023, 17:30
ACAD ACADIA PHARMACEUTICALS INC 01 Jun 2023 2 $0 4 Director 05 Jun 2023, 21:43
ACAD ACADIA PHARMACEUTICALS INC 12 Oct 2022 2 $0 4 Director 14 Oct 2022, 19:09
ACAD ACADIA PHARMACEUTICALS INC 12 Oct 2022 0 $0 3 Director 14 Oct 2022, 18:53
DBVT DBV Technologies S.A. 10 Jun 2021 1 +$48,679 4 Director 11 Jun 2021, 16:56
DBVT DBV Technologies S.A. 19 May 2021 0 $0 3 Director 01 Jun 2021, 16:44